132 related articles for article (PubMed ID: 3768243)
1. Partial metabolic clearances as determinants of the oral bioavailability of propranolol.
Walle T; Walle UK; Olanoff LS; Conradi EC
Br J Clin Pharmacol; 1986 Sep; 22(3):317-23. PubMed ID: 3768243
[TBL] [Abstract][Full Text] [Related]
2. Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects.
Walle T; Walle UK; Cowart TD; Conradi EC
Clin Pharmacol Ther; 1989 Sep; 46(3):257-63. PubMed ID: 2776391
[TBL] [Abstract][Full Text] [Related]
3. Selective induction of propranolol metabolism by smoking: additional effects on renal clearance of metabolites.
Walle T; Walle UK; Cowart TD; Conradi EC; Gaffney TE
J Pharmacol Exp Ther; 1987 Jun; 241(3):928-33. PubMed ID: 3598909
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective ring oxidation of propranolol in man.
Walle T; Walle UK; Wilson MJ; Fagan TC; Gaffney TE
Br J Clin Pharmacol; 1984 Nov; 18(5):741-8. PubMed ID: 6508983
[TBL] [Abstract][Full Text] [Related]
5. Racial differences in propranolol enantiomer kinetics following simultaneous i.v. and oral administration.
Sowinski KM; Lima JJ; Burlew BS; Massie JD; Johnson JA
Br J Clin Pharmacol; 1996 Sep; 42(3):339-46. PubMed ID: 8877025
[TBL] [Abstract][Full Text] [Related]
6. Quantitative account of propranolol metabolism in urine of normal man.
Walle T; Walle UK; Olanoff LS
Drug Metab Dispos; 1985; 13(2):204-9. PubMed ID: 2859169
[TBL] [Abstract][Full Text] [Related]
7. Stereochemical composition of propranolol metabolites in the dog using stable isotope-labeled pseudoracemates.
Walle T; Wilson MJ; Walle UK; Bai SA
Drug Metab Dispos; 1983; 11(6):544-9. PubMed ID: 6140137
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective increase in propranolol bioavailability during chronic dosing in the dog.
Bai SA; Wilson MJ; Walle UK; Walle T
J Pharmacol Exp Ther; 1983 Nov; 227(2):360-4. PubMed ID: 6631718
[TBL] [Abstract][Full Text] [Related]
9. Decreased absorption as a possible cause for the lower bioavailability of a sustained-release propranolol.
Takahashi H; Ogata H; Warabioka R; Kashiwada K; Ohira M; Someya K
J Pharm Sci; 1990 Mar; 79(3):212-5. PubMed ID: 2338628
[TBL] [Abstract][Full Text] [Related]
10. Presystemic and systemic glucuronidation of propranolol.
Walle T; Fagan TC; Conradi EC; Walle UK; Gaffney TE
Clin Pharmacol Ther; 1979 Aug; 26(2):167-72. PubMed ID: 455886
[TBL] [Abstract][Full Text] [Related]
11. Stimulatory as well as inhibitory effects of ethinyloestradiol on the metabolic clearances of propranolol in young women.
Walle T; Fagan TC; Walle UK; Topmiller MJ
Br J Clin Pharmacol; 1996 Apr; 41(4):305-9. PubMed ID: 8730976
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and metabolism of oral doses of a 4'-methylthio derivative of propranolol in man.
Walle T; Walle UK; Cowart TD; Conradi EC; Gaffney TE
Xenobiotica; 1990 Mar; 20(3):321-31. PubMed ID: 2336841
[TBL] [Abstract][Full Text] [Related]
13. Propranolol metabolism in normal subjects: association with sex steroid hormones.
Walle T; Walle K; Mathur RS; Palesch YY; Conradi EC
Clin Pharmacol Ther; 1994 Aug; 56(2):127-32. PubMed ID: 8062488
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of glucuronidation of propranolol following oral administration in humans.
Midha KK; Roscoe RM; Wilson TW; Cooper JK; Loo JC; Ho-Ngoc A; McGilveray IJ
Biopharm Drug Dispos; 1983; 4(4):331-8. PubMed ID: 6661512
[TBL] [Abstract][Full Text] [Related]
15. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
Vu VT; Bai SA; Abramson FP
J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
[TBL] [Abstract][Full Text] [Related]
16. The effect of ageing on the hepatic clearance of propranolol.
Castleden CM; George CF
Br J Clin Pharmacol; 1979 Jan; 7(1):49-54. PubMed ID: 760742
[TBL] [Abstract][Full Text] [Related]
17. Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis.
Olanoff LS; Walle T; Cowart TD; Walle UK; Oexmann MJ; Conradi EC
Clin Pharmacol Ther; 1986 Oct; 40(4):408-14. PubMed ID: 3757404
[TBL] [Abstract][Full Text] [Related]
18. Direct measurement of propranolol bioavailability during accumulation to steady-state.
Wood AJ; Carr K; Vestal RE; Belcher S; Wilkinson GR; Shand DG
Br J Clin Pharmacol; 1978 Oct; 6(4):345-50. PubMed ID: 698031
[TBL] [Abstract][Full Text] [Related]
19. Interaction between oral propranolol and hydralazine.
McLean AJ; Skews H; Bobik A; Dudley FJ
Clin Pharmacol Ther; 1980 Jun; 27(6):726-32. PubMed ID: 7379440
[TBL] [Abstract][Full Text] [Related]
20. No stereoselective first-pass hepatic extraction of propranolol.
Jackman GP; McLean AJ; Jennings GL; Bobik A
Clin Pharmacol Ther; 1981 Sep; 30(3):291-6. PubMed ID: 7273593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
